Author:
Ma Mingming,Gan Liangyu,Liu Yinhua,Jiang Yuan,Xin Ling,Liu Yi,Qin Naishan,Cheng Yuanjia,Liu Qian,Xu Ling,Zhang Yaofeng,Wang Xiangpeng,Zhang Xiaodong,Ye Jingming,Wang Xiaoying
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference21 articles.
1. Triple-negative breast cancer;Foulkes;N. Engl. J. Med.,2010
2. Differences in breast cancer survival by molecular subtypes in the United States, cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive;Howlader;Oncology,2018
3. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer;Liedtke;J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol.,2008
4. M. Golshan, C.T. Cirrincione, W.M. Sikov, D.A. Berry, S. Jasinski, T.F. Weisberg, G. Somlo, C. Hudis, E. Winer, D.W. Ollila, Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance), Ann. Surg. 262 (3) (2015) 434–439, discussion 438–439.
5. Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice;Saw;Breast Cancer Res. Treat.,2019
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献